Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation

Int J Hematol. 2007 Dec;86(5):466-7. doi: 10.1007/BF02984009.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Child
  • Child, Preschool
  • Epstein-Barr Virus Infections / complications
  • Epstein-Barr Virus Infections / therapy
  • Etoposide / administration & dosage*
  • Female
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / therapy
  • Lymphohistiocytosis, Hemophagocytic / blood
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Male
  • Remission Induction
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents, Phytogenic
  • Etoposide